Marieke and Wim de Niet founders of Hycult Biotech
The time was 1994, a very eventful year. In previous years I had gained some experience with antibodies as director and owner of Sanbio B.V., by being at the cradle of the phenomenon that universities were interested in commercializing their “intellectual properties”, antibodies they had developed in their research.
Prof. Wim Buurman (University Maastricht) with whom I had a close contact and who already stood beside me during the early years, was a great help in acquiring Holland Biotechnology established in Leiden. The company in Leiden had done its best to build their business, but due to their intense research activities, they did not succeed in establishing a worldwide distribution network. The Netherlands alone was too limited as a market for their specialized products.
Worldwide outlets
At Sanbio, I set up a distribution network that allowed us to have worldwide outlets. In 1994 the decision was made for me to take over the company and rename it from Holland to Hycult (Hybridoma culture) Biotechnology. In the beginning weeks came and went with one or two orders for the antibodies. Through sheer will and perseverance more orders came, in part due to dedication of fantastic employees in the research and production. Without the team of people I would never have been able to fulfil the expectations of the business.
A fully streamlined laboratory
Now, almost 30 years later, we can be proud of what we have achieved. A fully streamlined laboratory and a highly skilled team of employees who carry the whole in their hands. In addition, I am delighted that our son Ronald has been able to get
acquainted with the work in a short time and demonstrates the right commercial qualities to bring Hycult Biotech to an even higher level. TO BE PROUD OF, and I am indeed
Biocult
In 2019, Biocult became part of the Hycult Biotechnology B.V., enhancing its capabilities and product offerings.
Operating under the EN ISO 13485:2016 certified quality management system, Biocult ensures high-quality production standards. Our services include:
- Research & Developement: Design and optimization of antibodies and assays for various applications.
- Assay development
- Antibody validation sercives
- Manufacturing: Production of high-quality antibodies and ELISA kits under ISO 13485 standards.
- Monoclonal antibody manufacturing
- Assay manufacturing
- Lyophilization
- Plate coating
- Solution filling
With over 30 years of combined experience from both Biocult and Hycult Biotech, we are committed to supporting researchers in academia and industry by providing high-quality, customized solutions. Our goal is to facilitate advancements in understanding, monitoring, and treating diseases, particularly those related to innate immunity and the complement system.
Whether you require small-scale research quantities or large-scale production, Biocult is equipped to deliver products that meet your specifications, ensuring consistency and reliability in your research endeavors.